Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:50 PM UTC
| NCT Number | NCT05005403 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 694 participants |
| Active Locations | 20 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | June 23, 2026 (Jun 23, 2026) |
As of August 28, 2026: Clinical trial NCT05005403 is currently recruiting participants. This phase1 study for non-small cell lung cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05005403 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05005403 was last updated Jun 23, 2026 (June 23, 2026). HelloStudys verifies this status automatically.